Advertisement
Journal Home
Search for

Volume 48, Issue 3, Pages 295-313 (May 2003)


View previous. 3 of 10 View next.

Primary Open-Angle Glaucoma in Blacks: A Review

Lyne Racette, MA1, M.Roy Wilson, MD2, Linda M Zangwill, PhD1, Robert N Weinreb, MD1, Pamela A Sample, PhD1Corresponding Author Information

Abstract 

Glaucoma is one of the leading causes of blindness worldwide. Primary open-angle glaucoma (POAG) is the most prevalent form of glaucoma and has a particularly devastating impact in blacks. In the black American population, POAG prevalence is estimated to be six times as high in certain age groups compared to whites. POAG is more likely to result in irreversible blindness, appears approximately 10 years earlier and progresses more rapidly in blacks than in whites. Racial differences in optic disk parameters have been reported and show that blacks have larger optic disks than whites. This finding is robust and may account for the reported differences in other optic disk parameters. The existence of racial differences in intraocular pressure remains to be demonstrated, as conflicting findings are reported in the literature. Intraocular pressure may actually be underestimated in blacks, perhaps because they have thinner corneas. The prevalence of diabetes and hypertension is higher in blacks than in whites, and although no causal relationship has been established between POAG and each of these systemic diseases, some reports suggest that they often occur together, perhaps through an indirect relationship with intraocular pressure. Compounding the problem, there is evidence that blacks are less responsive to both drug and surgical treatment for POAG. Finally, they often have reduced accessibility to treatment and are less aware of the risks of having POAG. This article provides a comprehensive review of the current knowledge pertaining to POAG in blacks.

1 Glaucoma Center and Visual Function Laboratory, Department of Ophthalmology, University of California at San Diego, La Jolla, California, USA

2 Department of Ophthalmology, Creighton University, Omaha, Nebraska, USA

Corresponding Author InformationReprint address: Pamela A. Sample, PhD, Department of Ophthalmology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0946

 The authors wish to thank Dr. Tarek El Beltagi for reviewing earlier versions of the manuscript and Ms. Shannon Kleinhandler for her assistance. This article was supported by NIH grants EY08208 (PAS) and EY11008 (LZ), and the Glaucoma Research Foundation (PAS). The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(03)00028-6

doi:10.1016/S0039-6257(03)00028-6


View previous. 3 of 10 View next.

Advertisement